Items where Author is "Baghbanian, S. M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 10.

Article

(2022) Characteristics of COVID-19 in patients with multiple sclerosis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Epidemiology of familial multiple sclerosis in Iran: a national registry-based study. BMC NEUROLOGY. ISSN 1471-2377 J9 - BMC NEUROL

(2022) Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2021) Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study. Caspian J Intern Med. pp. 263-274. ISSN 2008-6164 (Print) 2008-6164

(2021) YY Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study. Caspian Journal of Internal Medicine. pp. 263-274. ISSN 2008-6164

(2019) Management of seizures in patients with multiple sclerosis; an Iranian consensus. Epilepsy & Behavior. ISSN 1525-5069 (Electronic) 1525-5050 (Linking)

(2019) Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set. Multiple Sclerosis and Related Disorders. pp. 158-161. ISSN 2211-0348

(2018) Primary progressive multiple sclerosis in Iran: A consensus recommendation for diagnosis and management. Mult Scler Relat Disord. pp. 112-120. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2017) Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Multiple Sclerosis and Related Disorders. pp. 144-151. ISSN 2211-0348

This list was generated on Thu Nov 21 17:08:39 2024 +0330.